Gabelli Funds LLC Reduces Position in UnitedHealth Group Incorporated $UNH

Key Points

• Gabelli Funds LLC cut its stake in UnitedHealth by 24.6% in Q3, selling 7,185 shares and ending the period with 21,985 shares valued at about $7.59 million.
• UnitedHealth beat quarterly EPS estimates ($2.11 vs. $2.09) with revenue of $113.73 billion (+12.3% YoY); the company set FY2026 EPS guidance at 17.75 while analysts’ consensus for the current fiscal year is roughly 29.54 and the consensus price target is $372.13.
• The company announced a quarterly dividend of $2.21 per share (annualized $8.84) payable March 17, with an ex-dividend date and record date on March 9, implying a ~3.1% yield.

Gabelli Funds LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 21,985 shares of the healthcare conglomerate's stock after selling 7,185 shares during the quarter. Gabelli Funds LLC's holdings in UnitedHealth Group were worth $7,591,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of UNH. LFA Lugano Financial Advisors SA purchased a new position in UnitedHealth Group during the 2nd quarter worth approximately $25,000. Sagard Holdings Management Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $29,000. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth $31,000. Hurley Capital LLC boosted its holdings in UnitedHealth Group by 81.6% in the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock valued at $31,000 after purchasing an additional 40 shares during the last quarter. Finally, Cloud Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.7%

Shares of NYSE:UNH opened at $286.86 on Monday. The firm has a market capitalization of $260.38 billion, a price-to-earnings ratio of 21.75, a price-to-earnings-growth ratio of 1.32 and a beta of 0.41. The business's 50 day moving average price is $308.28 and its 200-day moving average price is $326.02. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. The business had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company's revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm posted $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group's payout ratio is 67.02%.

Analyst Ratings Changes

A number of analysts have recently commented on UNH shares. Barclays lowered their target price on UnitedHealth Group from $391.00 to $327.00 and set an "overweight" rating on the stock in a research note on Friday, January 30th. UBS Group lowered their price objective on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating on the stock in a research report on Wednesday, January 28th. Oppenheimer cut their target price on shares of UnitedHealth Group from $415.00 to $385.00 and set an "outperform" rating for the company in a report on Wednesday, January 28th. Evercore raised shares of UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. Finally, Sanford C. Bernstein reiterated an "outperform" rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.